AstraZeneca Faslodex and Crystal Genomics Acelex will receive a 30% discount due to the government's authority adjustment. They are expected to fall 23.5% each in the second half of next year when the addition ends. Roflumilast formulations such as Sama Roflu 500μg and AstraZeneca Daxas 500μg of Korea, which has been receiving additional assets, will maintain their added value for two more years. According to the industry on the 24th, the Ministry of Health and Welfare plans to revise the "Amendment to the Drug Benefit List and the benefit limit table" and is pushing for application as of the 1st of next month. First of all, there are three items for authority adjustment. When the same product is registered, the govern